Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1092578-27-2

1092578-27-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1092578-27-2 Structure

  • Basic information

    1. Product Name: prednisone
    2. Synonyms: prednisone
    3. CAS NO:1092578-27-2
    4. Molecular Formula:
    5. Molecular Weight: 523.54
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1092578-27-2.mol
    9. Article Data: 2

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: prednisone(CAS DataBase Reference)
    10. NIST Chemistry Reference: prednisone(1092578-27-2)
    11. EPA Substance Registry System: prednisone(1092578-27-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1092578-27-2(Hazardous Substances Data)

1092578-27-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1092578-27-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,2,5,7 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1092578-27:
(9*1)+(8*0)+(7*9)+(6*2)+(5*5)+(4*7)+(3*8)+(2*2)+(1*7)=172
172 % 10 = 2
So 1092578-27-2 is a valid CAS Registry Number.

1092578-27-2Downstream Products

1092578-27-2Relevant articles and documents

Switch off/switch on regulation of drug cytotoxicity by conjugation to a cell targeting peptide

Gilad, Yossi,Firer, Michael A.,Rozovsky, Alex,Ragozin, Elena,Redko, Boris,Albeck, Amnon,Gellerman, Gary

, p. 139 - 146 (2014)

Bi-nuclear amino acid platforms loaded with various drugs for conjugation to a peptide carrier were synthesized using simple and convenient orthogonally protective solid-phase organic synthesis (SPOS). Each arm of the platform carries a different anticancer agent linked through the same or different functional group, providing discrete chemo-and bio-release profiles for each drug, and also enabling switch off/switch regulation of drug cytotoxicity by conjugation to the platform and to a cell targeting peptide. The versatility of this approach enables efficient production of drug-loaded platforms and determination of favorable drug combinations/modes of linkage for subsequent conjugation to a carrier moiety for targeted cancer cell therapy. The results presented here potentiate the application of amino acid platforms for targeted drug delivery (TDD).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1092578-27-2